Search research articles
Contact Us
Filters
Showing results (291-300 of 318) with videos related to
Page
of 32
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
January 2, 2024
Clofazimine pharmacokinetics in HIV-infected adults with diarrhea: Implications of diarrheal disease on absorption of orally administered therapeutics
Cindy X Zhang, Thomas M Conrad, David Hermann, et al.
Plos One
|
April 22, 2021
High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity
Ryan Choi, Mowei Zhou, Roger Shek, et al.
The Journal of Infectious Diseases
|
December 8, 2016
Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis
Deborah A Schaefer, Dana P Betzer, Kylie D Smith, et al.
The Journal of Infectious Diseases
|
November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis
Matthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
Antimicrobial Agents and Chemotherapy
|
July 4, 2007
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase
Wesley C Van Voorhis, Kasey L Rivas, Pravin Bendale, et al.
Scientific Reports
|
February 23, 2021
In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19
Isabelle Q Phan, Sandhya Subramanian, David Kim, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 29, 2022
Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron
Linhui Hao, Tien-Ying Hsiang, Ronit R Dalmat, et al.
ACS Infectious Diseases
|
March 19, 2021
Repurposing Infectious Disease Hits as Anti-<i>Cryptosporidium</i> Leads
Matthew A Hulverson, Ryan Choi, Molly C McCloskey, et al.
The Journal of Infectious Diseases
|
March 23, 2017
Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy
Matthew A Hulverson, Sumiti Vinayak, Ryan Choi, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
March 5, 2018
Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites
Roberto Sánchez-Sánchez, Ignacio Ferre, Michela Re, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 318) with videos related to
Sort By:
Page
of 32
CPT: Pharmacometrics & Systems Pharmacology
|
January 2, 2024
Clofazimine pharmacokinetics in HIV-infected adults with diarrhea: Implications of diarrheal disease on absorption of orally administered therapeutics
Cindy X Zhang, Thomas M Conrad, David Hermann, et al.
Plos One
|
April 22, 2021
High-throughput screening of the ReFRAME, Pandemic Box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity
Ryan Choi, Mowei Zhou, Roger Shek, et al.
The Journal of Infectious Diseases
|
December 8, 2016
Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis
Deborah A Schaefer, Dana P Betzer, Kylie D Smith, et al.
The Journal of Infectious Diseases
|
November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis
Matthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
Antimicrobial Agents and Chemotherapy
|
July 4, 2007
Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase
Wesley C Van Voorhis, Kasey L Rivas, Pravin Bendale, et al.
Scientific Reports
|
February 23, 2021
In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19
Isabelle Q Phan, Sandhya Subramanian, David Kim, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 29, 2022
Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron
Linhui Hao, Tien-Ying Hsiang, Ronit R Dalmat, et al.
ACS Infectious Diseases
|
March 19, 2021
Repurposing Infectious Disease Hits as Anti-<i>Cryptosporidium</i> Leads
Matthew A Hulverson, Ryan Choi, Molly C McCloskey, et al.
The Journal of Infectious Diseases
|
March 23, 2017
Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy
Matthew A Hulverson, Sumiti Vinayak, Ryan Choi, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
March 5, 2018
Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites
Roberto Sánchez-Sánchez, Ignacio Ferre, Michela Re, et al.
Page
of 32